Keith Hoffman, PhD

Keith is the vice president of scientific affairs at Advera Health Analytics (previously AdverseEvents Inc). He has 17 years of science, business, and intellectual property development experience in the biotechnology, pharmaceutical, and consumer goods industries. Prior to Advera Health Analytics, he was the chief business officer of Antigen Discovery, chief operation officer (COO) of ChemoTherapeutics, COO of LALO Tactical, COO of Thuris Corporation, and Head of Scientific Affairs at Ancile Pharmaceuticals. Keith has a PhD in Neuropharmacology from the laboratory of Gary Lynch and an undergraduate degree in biology, both from UC Irvine.